Lundbeck
HLUN-B.CO
#2869
Rank
S$5.71 B
Marketcap
$5.94
Share price
0.47%
Change (1 day)
-7.95%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.48

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.47. In 2022 the company made an earnings per share (EPS) of $0.35 a decrease over its 2021 EPS that were of $0.79.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.4836.3%
2022$0.35-55.47%
2021$0.79-51.83%
2020$1.65-28.01%
2019$2.29-44.08%
2018$4.1051.94%
2017$2.70126.64%
2016$1.19-120.84%
2015-$5.715622.18%
2014-$0.09977-110.03%
2013$0.99-28.08%
2012$1.38-52.1%
2011$2.89-1.31%
2010$2.9215.61%
2009$2.53